Dr. Antonio Crespo is an interdisciplinary scientist and executive with a unique background bridging artificial intelligence, systems engineering, and biomedical innovation. Holding a PhD in Information and Systems Engineering from Concordia University and a master’s in Computer Science from the University of Brasília, his research spans AI-driven modeling, neuronal systems, and predictive healthcare technologies. He is the CEO and founder of DreamerGate R&D Ent. Inc. and serves as Scientific Advisor for AI at the Canadian MPN Group. Dr. Crespo has played a leading role in projects involving AI-supported prediction in chronic myeloid leukemia and healthcare-focused generative models. Trained in drug development, discovery, and commercialization at the University of California, San Diego, he combines technical acumen with translational insight to advance innovation at the intersection of AI and life sciences.